About

TreatHF App Now Updated

April 30, 2021

The ACC TreatHF app helps clinicians confirm which therapies are suggested for their patients with symptomatic heart failure with reduced ejection fraction (stage C HFrEF) and provides guidance on the use of each therapy. The app was recently updated for an improved user experience, providing an expanded Therapy Reference section and new content from the “2021 Update to the 2017 ECDP for Optimization of Heart Failure Treatment,” including information regarding use of angiotensin receptor-neprilysin inhibitors (ARNIs) as de novo therapy, and sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure. Download the app and check out ACC's mobile resources at ACC.org/Apps
 

Print